Mesenchymal stromal cells and their small extracellular vesicles in allergic diseases: From immunomodulation to therapy
European Journal of Immunology · 2023
DOI: 10.1002/eji.202149510 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Immunology, 2023. Verfasst von Ya-Qi Peng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, MicroRNAs, Asthma, Mesenchymal Stem Cells. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Mesenchymal stromal cells (MSCs) have long been considered a potential tool for treatment of allergic inflammatory diseases, owing to their immunomodulatory characteristics. In recent decades, the medical utility of MSCs has been evaluated both in vitro and in vivo, providing a foundation for therapeutic applications. However, the existing limitations of MSC therapy indicate the necessity for novel therapies. Notably, small extracellular vesicles (sEV) derived from MSCs have emerged rapidly as candidates instead of their parental cells. The acquisition of abundant and scalable MSC‐sEV is an obstacle for clinical applications. The potential application of MSC‐sEV in allergic diseases has attracted increasing attention from researchers. By carrying biological microRNAs or active proteins, MSC‐sEV can modulate the function of various innate and adaptive immune cells. In this review, we summarise the recent advances in the immunomodulatory properties of MSCs in allergic diseases, the cellular sources of MSC‐sEV, and the methods for obtaining high‐quality human MSC‐sEV. In addition, we discuss the immunoregulatory capacity of MSCs and MSC‐sEV for the treatment of asthma, atopic dermatitis, and allergic rhinitis, with a special emphasis on their immunoregulatory effects and the underlying mechanisms of immune cell modulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Otolaryngology-Head and Neck Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
- Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University, Guangzhou, China.
ORCID-Profile: Qing-Ling Fu
Zitieren
APA
Peng, Y. Q., Deng, X. H., Xu, Z. B., Wu, Z. C., & Fu, Q. L. (2023). Mesenchymal stromal cells and their small extracellular vesicles in allergic diseases: From immunomodulation to therapy. European Journal of Immunology. https://doi.org/10.1002/eji.202149510
Vancouver
Peng YQ, Deng XH, Xu ZB, Wu ZC, Fu QL. Mesenchymal stromal cells and their small extracellular vesicles in allergic diseases: From immunomodulation to therapy. European Journal of Immunology. 2023. doi:10.1002/eji.202149510
BibTeX
@article{Peng2023,
author = {Peng, Ya-Qi and Deng, Xiao-Hui and Xu, Zhi-Bin and Wu, Zi-Cong and Fu, Qing-Ling},
title = {Mesenchymal stromal cells and their small extracellular vesicles in allergic diseases: From immunomodulation to therapy},
journal = {European Journal of Immunology},
year = {2023},
doi = {10.1002/eji.202149510}
}
EUVIMED